Brazil plans to expand a crackdown on companies that patent products made from rare plants and animals without adequately compensating the South American country or its indigenous communities.
The fight against “biopiracy” has won the support of indigenous communities and defenders of the Amazon rain forest who say corporations unfairly benefit from medicine and other products derived from Brazil’s exotic plants, poisonous snakes or brightly colored frogs.
However, the effort has sparked criticism that it slows crucial scientific research and arbitrarily targets entrepreneurs that could develop environmentally sustainable businesses.
Brazil has levied more than 100 million reais (US$59 million) in fines since July on companies charged with not paying fair compensation for the use of genetic material native to Brazil, said Bruno Barbosa, who heads inspection for the environmental oversight agency Ibama.
Next year, officials will begin pursuing companies that did not notify the government of their use of local species to create products such as pharmaceuticals, as required by law, meaning fines will likely go up.
“Given that [fighting biopiracy] is a new process and that Brazil has one of the biggest reserves of biodiversity in the world, I think most of this activity is illegal, and we’re going to find those people,” he said.
Barbosa says examples of biopiracy abound, such as the development in the 1970s of the hypertension medication captopril from a snake venom that indigenous groups used on arrowhead tips.
Pharmaceuticals companies also used the yellow-and-green Kambo frog, found in Brazil’s Amazon state of Acre, to create anti-inflammatory drugs without distributing benefits to local residents, he said. Many of these incidents came before a 2001 decree that created the current rules governing species use.
The government this year stepped up the anti-biopiracy effort with a campaign known as “Operation New Direction” that aims to crack down on what it calls profiteering.
Fines next year may rise to US$29 million each and companies face possible cancelation of patents in Brazil if inspectors find they did not register the use of local species.
One of the biggest fines levied so far was on Brazil’s largest cosmetics maker Natura, Barbosa said. He declined to give details on the amount or the infraction because the process is ongoing.
Critics say Brazil’s often aggressive efforts to prevent biopiracy threaten to slow crucial scientific research that could provide new cancer treatments or remedies for diseases suffered by local populations.
They said it treats anyone interested in commercial use of rare species as possibly criminal, complicating government goals of developing research facilities near where the species are found to create jobs in those communities.
The government should make the rules clearer because the current system ends up penalizing those that make the most effort to be transparent about their use of genetic material, said Raul Telles do Valle who works with ISA, a think tank on social and environmental issues.
“The current law is very vague on a lot of points, it ends up classifying everybody as illegitimate,” he said. “Just passing out fines under the existing framework isn’t going to solve the problem.”
The law should reflect the difficulty of determining how to compensate local populations from collective knowledge passed down over generations, he said.
Barbosa says the government’s legislation is suitable and that expanding the fight against biopiracy could reduce the destruction of sensitive environments.
“This is going to enable concrete alternatives that substitute destruction of the ecosystem for new economic mechanisms,” he said.
SEMICONDUCTORS: The firm has already completed one fab, which is to begin mass producing 2-nanomater chips next year, while two others are under construction Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, plans to begin construction of its fourth and fifth wafer fabs in Kaohsiung next year, targeting the development of high-end processes. The two facilities — P4 and P5 — are part of TSMC’s production expansion program, which aims to build five fabs in Kaohsiung. TSMC facility division vice president Arthur Chuang (莊子壽) on Thursday said that the five facilities are expected to create 8,000 jobs. To respond to the fast-changing global semiconductor industry and escalating international competition, TSMC said it has to keep growing by expanding its production footprints. The P4 and P5
DOWNFALL: The Singapore-based oil magnate Lim Oon Kuin was accused of hiding US$800 million in losses and leaving 20 banks with substantial liabilities Former tycoon Lim Oon Kuin (林恩強) has been declared bankrupt in Singapore, following the collapse of his oil trading empire. The name of the founder of Hin Leong Trading Pte Ltd (興隆貿易) and his children Lim Huey Ching (林慧清) and Lim Chee Meng (林志朋) were listed as having been issued a bankruptcy order on Dec. 19, the government gazette showed. The younger Lims were directors at the company. Leow Quek Shiong and Seah Roh Lin of BDO Advisory Pte Ltd are the trustees, according to the gazette. At its peak, Hin Leong traded a range of oil products, made lubricants and operated loading
The growing popularity of Chinese sport utility vehicles and pickup trucks has shaken up Mexico’s luxury car market, hitting sales of traditionally dominant brands such as Mercedes-Benz and BMW. Mexicans are increasingly switching from traditionally dominant sedans to Chinese vehicles due to a combination of comfort, technology and price, industry experts say. It is no small feat in a country home to factories of foreign brands such as Audi and BMW, and where until a few years ago imported Chinese cars were stigmatized, as in other parts of the world. The high-end segment of the market registered a sales drop
Citigroup Inc and Bank of America Corp said they are leaving a global climate-banking group, becoming the latest Wall Street lenders to exit the coalition in the past month. In a statement, Citigroup said while it remains committed to achieving net zero emissions, it is exiting the Net-Zero Banking Alliance (NZBA). Bank of America said separately on Tuesday that it is also leaving NZBA, adding that it would continue to work with clients on reducing greenhouse gas emissions. The banks’ departure from NZBA follows Goldman Sachs Group Inc and Wells Fargo & Co. The largest US financial institutions are under increasing pressure